Michael A. Ströhlein

1.4k total citations
24 papers, 1.1k citations indexed

About

Michael A. Ströhlein is a scholar working on Surgery, Reproductive Medicine and Oncology. According to data from OpenAlex, Michael A. Ströhlein has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 9 papers in Reproductive Medicine and 7 papers in Oncology. Recurrent topics in Michael A. Ströhlein's work include Intraperitoneal and Appendiceal Malignancies (14 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Michael A. Ströhlein is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (14 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Michael A. Ströhlein collaborates with scholars based in Germany, France and Australia. Michael A. Ströhlein's co-authors include M. M. Heiss, Karl‐Walter Jauch, Horst Lindhofer, Rainer Kimmig, Alexander Burges, Michael Jäger, Barbara Schmalfeldt, Pauline Wimberger, Michael Jäger and A. Schoberth and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Michael A. Ströhlein

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Ströhlein Germany 16 570 497 220 212 175 24 1.1k
Manuel J. Koppe Netherlands 14 483 0.8× 182 0.4× 171 0.8× 23 0.1× 212 1.2× 19 833
P H de Mulder Netherlands 13 272 0.5× 322 0.6× 84 0.4× 220 1.0× 33 0.2× 18 754
Marc Pocard France 15 598 1.0× 754 1.5× 82 0.4× 18 0.1× 80 0.5× 25 1.1k
Chaoqun Huang China 15 754 1.3× 148 0.3× 347 1.6× 47 0.2× 16 0.1× 29 1.1k
Haruhiko Imamoto Japan 19 842 1.5× 368 0.7× 102 0.5× 47 0.2× 33 0.2× 70 1.4k
Carlos Fernández‐del‐Castillo United States 14 627 1.1× 657 1.3× 21 0.1× 75 0.4× 103 0.6× 17 1.0k
I. Benjamin Paz United States 15 677 1.2× 607 1.2× 28 0.1× 44 0.2× 23 0.1× 48 1.4k
Fernando O. Recio United States 19 371 0.7× 181 0.4× 416 1.9× 60 0.3× 21 0.1× 45 994
Takeshi Tono Japan 14 397 0.7× 196 0.4× 21 0.1× 116 0.5× 55 0.3× 90 783
Mary Hesdorffer United States 15 179 0.3× 343 0.7× 27 0.1× 117 0.6× 106 0.6× 27 1.5k

Countries citing papers authored by Michael A. Ströhlein

Since Specialization
Citations

This map shows the geographic impact of Michael A. Ströhlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Ströhlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Ströhlein more than expected).

Fields of papers citing papers by Michael A. Ströhlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Ströhlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Ströhlein. The network helps show where Michael A. Ströhlein may publish in the future.

Co-authorship network of co-authors of Michael A. Ströhlein

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Ströhlein. A scholar is included among the top collaborators of Michael A. Ströhlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Ströhlein. Michael A. Ströhlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lange, J., et al.. (2020). Transvaginal hybrid-NOTES vs. traditional laparoscopic sigmoid resection for diverticulitis: a short-term comparative study. Scientific Reports. 10(1). 22321–22321. 4 indexed citations
2.
Rau, Beate, Andreas Brandl, Pompiliu Piso, et al.. (2019). Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer. 23(1). 11–22. 89 indexed citations
3.
4.
Proneth, Andrea, Andreas A. Schnitzbauer, Peter Schenker, et al.. (2018). Extended Pancreas Donor Program—The EXPAND Study. Transplantation. 102(8). 1330–1337. 22 indexed citations
5.
Piso, Pompiliu, Beate Rau, Alfred Königsrainer, et al.. (2018). Morbidity and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Data from the DGAV StuDoQ Registry with 2149 Consecutive Patients. Annals of Surgical Oncology. 26(1). 148–154. 35 indexed citations
6.
Ströhlein, Michael A., M. M. Heiss, & Karl‐Walter Jauch. (2016). The current status of immunotherapy in peritoneal carcinomatosis. Expert Review of Anticancer Therapy. 16(10). 1019–1027. 19 indexed citations
7.
Bulian, Dirk R., et al.. (2014). Transvaginal hybrid NOTES cholecystectomy—results of a randomized clinical trial after 6 months. Langenbeck s Archives of Surgery. 399(6). 717–724. 15 indexed citations
8.
Ströhlein, Michael A., Rolf Lefering, Dirk R. Bulian, & M. M. Heiss. (2014). Relative lymphocyte count is a prognostic parameter in cancer patients with catumaxomab immunotherapy. Medical Hypotheses. 82(3). 295–299. 12 indexed citations
9.
Heiss, M. M., Michael A. Ströhlein, Carsten Bokemeyer, et al.. (2014). The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study. Clinical Cancer Research. 20(12). 3348–3357. 18 indexed citations
10.
Brücher, Björn L.D.M., Pompiliu Piso, Victor J. Verwaal, et al.. (2012). Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–-Overview and Basics. Cancer Investigation. 30(3). 209–224. 83 indexed citations
11.
12.
Bulian, Dirk R., et al.. (2012). Appendectomy in Germany—an analysis of a nationwide survey 2011/2012. International Journal of Colorectal Disease. 28(1). 127–138. 12 indexed citations
13.
Ströhlein, Michael A., Florian Lordick, Dominik Rüttinger, et al.. (2011). Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial. Onkologie. 34(3). 101–108. 59 indexed citations
14.
Jäger, Michael, A. Schoberth, Peter Ruf, et al.. (2011). Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM × Anti-CD3). Cancer Research. 72(1). 24–32. 88 indexed citations
15.
Ströhlein, Michael A., Robert Siegel, Michael Jäger, et al.. (2009). Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis. Journal of Experimental & Clinical Cancer Research. 28(1). 18–18. 34 indexed citations
16.
Ströhlein, Michael A., et al.. (2008). Comparison of Laparoscopic vs. Open Access Surgery in Patients with Rectal Cancer: A Prospective Analysis. Diseases of the Colon & Rectum. 51(4). 385–391. 126 indexed citations
17.
Ströhlein, Michael A. & M. M. Heiss. (2007). Immunotherapy of Peritoneal Carcinomatosis. PubMed. 134. 483–491. 8 indexed citations
18.
Heiss, M. M., Michael A. Ströhlein, Michael Jäger, et al.. (2005). Immunotherapy of malignant ascites with trifunctional antibodies. International Journal of Cancer. 117(3). 435–443. 91 indexed citations
19.
20.
Heiss, M. M., Peter Fraunberger, Heike Allgayer, et al.. (1997). MODULATION OF IMMUNE RESPONSE BY BLOOD TRANSFUSION: EVIDENCE FOR A DIFFERENTIAL EFFECT OF ALLOGENEIC AND AUTOLOGOUS BLOOD IN COLORECTAL CANCER SURGERY. Shock. 8(6). 402–408. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel J. Koppe Breakdown of academic impact, for papers by P H de Mulder Breakdown of academic impact, for papers by Marc Pocard Breakdown of academic impact, for papers by Chaoqun Huang Breakdown of academic impact, for papers by Haruhiko Imamoto Breakdown of academic impact, for papers by Carlos Fernández‐del‐Castillo Breakdown of academic impact, for papers by I. Benjamin Paz Breakdown of academic impact, for papers by Fernando O. Recio Breakdown of academic impact, for papers by Takeshi Tono Breakdown of academic impact, for papers by Mary Hesdorffer
Rankless by CCL
2026